BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17908960)

  • 1. The proangiogenic phenotype of tumor-derived endothelial cells is reverted by the overexpression of platelet-activating factor acetylhydrolase.
    Doublier S; Ceretto M; Lupia E; Bravo S; Bussolati B; Camussi G
    Clin Cancer Res; 2007 Oct; 13(19):5710-8. PubMed ID: 17908960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor inactivation by local expression of platelet-activating factor acetyl-hydrolase modifies tumor vascularization and growth.
    Biancone L; Cantaluppi V; Del Sorbo L; Russo S; Tjoelker LW; Camussi G
    Clin Cancer Res; 2003 Sep; 9(11):4214-20. PubMed ID: 14519648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X; Ottino P; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor synthesis and response on pancreatic islet endothelial cells: relevance for islet transplantation.
    Biancone L; Cantaluppi V; Romanazzi GM; Russo S; Figliolini F; Beltramo S; Scalabrino E; Deregibus MC; Romagnoli R; Franchello A; Salizzoni M; Perin PC; Ricordi C; Segoloni GP; Camussi G
    Transplantation; 2006 Feb; 81(4):511-8. PubMed ID: 16495796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural-cell adhesion molecule (NCAM) expression by immature and tumor-derived endothelial cells favors cell organization into capillary-like structures.
    Bussolati B; Grange C; Bruno S; Buttiglieri S; Deregibus MC; Tei L; Aime S; Camussi G
    Exp Cell Res; 2006 Apr; 312(6):913-24. PubMed ID: 16406048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism.
    Camussi G; Montrucchio G; Lupia E; De Martino A; Perona L; Arese M; Vercellone A; Toniolo A; Bussolino F
    J Immunol; 1995 Jun; 154(12):6492-501. PubMed ID: 7539022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress.
    Noto H; Hara M; Karasawa K; Iso-O N; Satoh H; Togo M; Hashimoto Y; Yamada Y; Kosaka T; Kawamura M; Kimura S; Tsukamoto K
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):829-35. PubMed ID: 12649088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor growth, angiogenesis and inflammation in mice lacking receptors for platelet activating factor (PAF).
    Ferreira MA; Barcelos LS; Teixeira MM; Bakhle YS; Andrade SP
    Life Sci; 2007 Jun; 81(3):210-7. PubMed ID: 17588613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor receptor (PAF-R) and acetylhydrolase (PAF-AH) are co-expressed in immature bovine trophoblast giant cells throughout gestation, but not at parturition.
    Bücher K; Leiser R; Tiemann U; Pfarrer C
    Prostaglandins Other Lipid Mediat; 2006 Mar; 79(1-2):74-83. PubMed ID: 16516811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase.
    Tsironis LD; Mitsios JV; Milionis HJ; Elisaf M; Tselepis AD
    Cardiovasc Res; 2004 Jul; 63(1):130-8. PubMed ID: 15194469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
    Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
    Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis.
    Gomes RN; Bozza FA; Amâncio RT; Japiassú AM; Vianna RC; Larangeira AP; Gouvêa JM; Bastos MS; Zimmerman GA; Stafforini DM; Prescott SM; Bozza PT; Castro-Faria-Neto HC
    Shock; 2006 Jul; 26(1):41-9. PubMed ID: 16783197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mechanism for regulation of plasma platelet-activating factor acetylhydrolase expression in mammalian cells.
    Gardner AA; Reichert EC; Alexander TS; Topham MK; Stafforini DM
    Biochem J; 2010 May; 428(2):269-79. PubMed ID: 20331434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet activating factor production and proinflammatory gene expression in endotoxin-challenged bovine mammary endothelial cells.
    Corl CM; Gandy JC; Sordillo LM
    J Dairy Sci; 2008 Aug; 91(8):3067-78. PubMed ID: 18650283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasma platelet-activating factor acetylhydrolase (PAF-AH) deficiency as a risk factor for stroke].
    Satoh K
    Brain Nerve; 2008 Nov; 60(11):1319-24. PubMed ID: 19069165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropilin2 expressed in gastric cancer endothelial cells increases the proliferation and migration of endothelial cells in response to VEGF.
    Kim WH; Lee SH; Jung MH; Seo JH; Kim J; Kim MA; Lee YM
    Exp Cell Res; 2009 Aug; 315(13):2154-64. PubMed ID: 19409892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of human breast tumor-derived endothelial cells.
    Grange C; Bussolati B; Bruno S; Fonsato V; Sapino A; Camussi G
    Oncol Rep; 2006 Feb; 15(2):381-6. PubMed ID: 16391858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor acetylhydrolase: selective inhibition by potent n-alkyl methylphosphonofluoridates.
    Quistad GB; Fisher KJ; Owen SC; Klintenberg R; Casida JE
    Toxicol Appl Pharmacol; 2005 Jun; 205(2):149-56. PubMed ID: 15893542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-mediated gene transfer and lipoprotein-mediated protein delivery of plasma PAF-AH ameliorates proteinuria in rat model of glomerulosclerosis.
    Iso-O N; Noto H; Hara M; Togo M; Karasawa K; Ohashi N; Noiri E; Hashimoto Y; Kadowaki T; Kimura S; Watanabe T; Tsukamoto K
    Mol Ther; 2006 Jan; 13(1):118-26. PubMed ID: 16213192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.